Literature DB >> 8109651

Panic and panic disorder in the United States.

W W Eaton1, R C Kessler, H U Wittchen, W J Magee.   

Abstract

OBJECTIVE: The goal of this study was to determine the prevalence of DSM-III-R panic disorder and to describe its correlates.
METHOD: The study was part of the National Comorbidity Survey, the first psychiatric epidemiologic survey of the entire U.S. population and the first to use DSM-III-R criteria for diagnosis. The 8,098 survey respondents, aged 15-54 years, were given the Composite International Diagnostic Interview. For this report, the data on panic were analyzed, and from them the prevalence of panic disorder and related experiences in the U.S. population was estimated.
RESULTS: About 15% of the survey respondents reported the occurrence of a panic attack over their lifetimes, and 3% reported a panic attack in the preceding month. About 1% met the DSM-III-R criteria for panic disorder in the month preceding the interview. Panic attacks and panic disorder had a bimodal age distribution and were associated with female sex and lower educational achievement. Fifty percent of the survey respondents with panic disorder reported no symptoms of agoraphobia. The pattern of prevalence of correlated sociodemographic factors was similar for persons with panic attacks, panic disorder, and panic disorder with agoraphobia.
CONCLUSIONS: There appears to be no obvious threshold for the diagnosis of panic disorder. Panic disorder and agoraphobia, although highly comorbid, also occur separately.

Entities:  

Mesh:

Year:  1994        PMID: 8109651     DOI: 10.1176/ajp.151.3.413

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  37 in total

1.  Likelihood formulation of parent-of-origin effects on segregation analysis, including ascertainment.

Authors:  Fatemeh Haghighi; Susan E Hodge
Journal:  Am J Hum Genet       Date:  2001-11-30       Impact factor: 11.025

2.  The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI).

Authors:  Ronald C Kessler; T Bedirhan Ustün
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

3.  Cost effectiveness of acute imipramine therapy versus two imipramine maintenance treatment regimens for panic disorder.

Authors:  M R Mavissakalian; J K Schmier; J A Flynn; D A Revicki
Journal:  Pharmacoeconomics       Date:  2000-10       Impact factor: 4.981

4.  Health care use and quality of life among patients with asthma and panic disorder.

Authors:  Jonathan M Feldman; Paul M Lehrer; Soo Borson; Teal S Hallstrand; Mahmood I Siddique
Journal:  J Asthma       Date:  2005-04       Impact factor: 2.515

5.  Depressive disorders and panic attacks in women with bladder pain syndrome/interstitial cystitis: a population-based sample.

Authors:  Katherine E Watkins; Nicole Eberhart; Lara Hilton; Marika J Suttorp; Kimberly A Hepner; J Quentin Clemens; Sandra H Berry
Journal:  Gen Hosp Psychiatry       Date:  2011-02-18       Impact factor: 3.238

6.  Evidence for linkage and association of GABRB3 and GABRA5 to panic disorder.

Authors:  Laura M Hodges; Abby J Fyer; Myrna M Weissman; Mark W Logue; Fatemeh Haghighi; Oleg Evgrafov; Allessandro Rotondo; James A Knowles; Steven P Hamilton
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

7.  Panic attacks as risk markers for mental disorders*.

Authors:  Andrew J Baillie; Ronald M Rapee
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-03       Impact factor: 4.328

8.  The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Robert Jin; Ayelet Meron Ruscio; Katherine Shear; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2006-04

9.  Clinical and subthreshold panic disorder.

Authors:  Alexander Bystritsky; Lauren Kerwin; Noosha Niv; Jaime L Natoli; Natalie Abrahami; Ruth Klap; Kenneth Wells; Alexander S Young
Journal:  Depress Anxiety       Date:  2010-04       Impact factor: 6.505

10.  Early intervention in panic: randomized controlled trial and cost-effectiveness analysis.

Authors:  Peter Meulenbeek; Godelief Willemse; Filip Smit; Anton van Balkom; Philip Spinhoven; Pim Cuijpers
Journal:  Trials       Date:  2008-11-27       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.